GB:APTA Stock Latest News
Company AnnouncementsAptamer Group lifts revenue and cash as licensing and pharma demand deepen2w ago
Company AnnouncementsAptamer Group Sets Analyst and Investor Meetings for Full-Year Results3w ago
Company AnnouncementsAptamer Group Adds Cavendish as Joint Corporate Broker to Bolster Investor Reach2M ago
Company AnnouncementsAptamer Group boosts director stakes and launches major incentive scheme2M ago- Company AnnouncementsAptamer Group lifts revenue and pipeline as high-margin licensing takes hold3M ago
Company AnnouncementsAptamer Group moves to plug Ebola testing gap with Bundibugyo diagnostic push3M agoCompany AnnouncementsAptamer Group advances AI-driven discovery, automation and therapeutic pipeline after fundraise4M ago
Company AnnouncementsAptamer Group Wins Shareholder Backing for £4.55m Fundraise6M ago
Company AnnouncementsAptamer Group Raises £4.5m in Funding Round Ahead of Key Shareholder Vote7M ago
Company AnnouncementsAptamer Group opens £0.5m retail offer alongside £4.3m placing7M ago
Company AnnouncementsAptamer Group Raises £4.3m to Accelerate AI and Radiopharmaceutical Growth Plans7M ago
Company AnnouncementsAptamer Group lifts revenues and extends cash runway as Optimer deals scale up7M agoCompany AnnouncementsAptamer Group launches £3.75m equity raise to fund AI-enabled discovery and pipeline expansion7M ago
Company AnnouncementsAptamer Group launches Optimer radiopharmaceutical push with Radiopharmium7M ago
Company AnnouncementsAptamer Group Updates Status of EMI Share Option Block Listing7M ago- Company AnnouncementsAptamer Group hits key milestone in Metir pathogen detector collaboration8M ago
- Company AnnouncementsAptamer’s Optimer Tech Powers Twist Bioscience’s New TrueAmp NGS Library Prep Kit8M ago
- Company AnnouncementsAptamer Group Secures New Pharma Contracts and First Cash from Optimer Licensing9M ago
Company AnnouncementsAptamer Group Reasserts Cash Runway to June 2027 Amid Media Speculation9M agoCompany AnnouncementsAptamer Group lifts H1 revenue 27% as licensing push builds recurring income9M ago
Company AnnouncementsAptamer Group Secures Second Enzyme-Modulation Licence with Alphazyme for Hot-Start PCR Optimer10M ago